As a physician, my goal is to deliver radiation therapy that is personalized for each patient, an approach that can lead to improved survival for women with breast cancer. When I began my career 20 years ago, we treated all women with breast cancer the same way. Now we know that there are no routine breast cancers and that there is not just one way to prevent, detect and treat breast cancer. There are many types of breast cancer, and each woman is an individual, which means it is important to provide a targeted treatment plan for each patient.
Throughout my career I have served as the principal investigator on important clinical studies that have helped establish today’s standard of care for treating breast cancer patients. My research focuses on developing new technologies for individualized breast radiation treatment that will lead to better outcomes and fewer side effects, if any.
Radiation science is not an exact science. Many times we have resounding success, but not in every case. So I am developing and implementing new technologies, such as prone, conformal, partial breast and image-guided therapies, to provide radiation technology and tools that are capable of delivering a more precise dosage of radiation without harming healthy tissue or organs.
I have published my work extensively in the top research journals in the field. I am often asked to present my work at scientific meetings, and I split my time between patients, research, teaching and numerous leadership positions, both at Ohio State and nationally.
My focus on personalized treatments has led to some national prominence in the field as a national leader in radiation oncology. I have held many positions for national organizations. Since 2007, I have chaired the Breast Cancer Committee for the Radiation Therapy Oncology Group (RTOG). This group receives National Cancer Institute funding to conduct clinical trials, so in this role, I oversee all of the breast radiation clinical trials. Nearly 7,000 breast cancer patients will be enrolled in clinical trials under my oversight.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
Michigan State University
7/1/1989 - 6/30/1993
Specialties and conditions I treat
- Radiation Oncology
- Carcinoma, Ductal, Breast
- Papilloma, Intraductal
- Hereditary Breast and Ovarian Cancer Syndrome
- Carcinoma, Lobular
- Male Breast Cancer
- Inflammatory Breast Cancers
- Carcinoma, Medullary
- Adenocarcinoma, Mucinous
- Krukenberg Tumor
- Carcinoma, Mucoepidermoid
Locations where I practice
More about my work
American Board of Radiology (Subspecialty: Radiation Oncology)
News about me
- Ohio State Receives Top Rating From National Cancer Institute — ‘Exceptional’ — Re-Designated As Comprehensive Cancer Center
- Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence
- Experts Say Body Position in Breast Cancer Radiation Treatment Matters
- International Expert In Breast Radiation Oncology Joins The James
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/17, Dr. White has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Qfix Systems